RE: RE: RE: RE: RE: Econiche is the culprit Tson, I hope you are right. But the VMC would only be a profit center if we have enough orders to offset the cost of running it. Right now, there is no sign of orders coming from Canada where Econiche is its own native son. And if there is a standing orders in a rock solid promised order in the Eurasia regions, why are we so desperately seeking partners with upfront money? As for third parties vaccine manufacturing contracts, that would be a good way to generate revenue for the VMC. But there is no yalk yet and we don't know how much need there is out there.
BTW, Graeme also talk a good game about companies out there interested in buying some of our product lines. But if all assets have ben used as securities for the various loans save Urocidin, can we sell them without any legal repercussion?